Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis.
about
Polymorphonuclear neutrophil function in systemic sclerosis.Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up.New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitisEnhanced migration of fibroblasts derived from lungs with fibrotic lesions.Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis.Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosisActivated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseasesEffects of an inhaled corticosteroid, budesonide, on alveolar macrophage function in smokersEvidence for protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosisImaging of pulmonary disease in scleroderma with J001X scintigraphy.Clinical aspects of systemic sclerosis (scleroderma).Lung-restricted macrophage activation in the pearl mouse model of Hermansky-Pudlak syndrome.99mTc-MIBI Lung Scintigraphy in the Assessment of Pulmonary Involvement in Interstitial Lung Disease and Its Comparison With Pulmonary Function Tests and High-Resolution Computed Tomography: A Preliminary Study.Early pulmonary disease in systemic sclerosis: a comparison between carbon monoxide transfer factor and static lung complianceThe cytokine language of monocytes and macrophages in systemic sclerosis.
P2860
Q33557403-99AB8293-7E12-4A1D-90DE-414430AEF1D9Q33604601-EAB2F7FE-89DC-4E6C-8AF9-B9D673671437Q33604630-9981DFE9-2A01-4D10-B201-D5BE136EFDCAQ33605171-B66B8304-6199-427A-8788-DF32987C63AFQ35548257-B742DAA2-F205-4F4F-8D45-09F6078EB340Q35588318-A4EB008D-3653-45B0-8F0A-24600E94E55FQ36176957-BC2EDABE-0BAA-42F2-AE06-70BA10C855D9Q36220579-6DEBF0A0-2449-4E32-8710-C97669B6692AQ36225851-87E6CBD4-C7F9-4814-8A40-116BD658537EQ36566458-4147852A-4770-47D0-8F88-DBDCF2D61AC7Q36824545-66B09553-A20C-4B08-A664-915F57E77C31Q37198871-9D95D039-4696-4C60-A951-03B8734547CCQ37328602-39CE14E4-DA92-4042-B512-DE45F1781823Q41267164-D5137752-675C-496A-97FF-8F3CE2AC275BQ42345689-EFB94704-D026-40EF-9C07-BC965A701775
P2860
Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Evidence for chronic inflammat ...... rogressive systemic sclerosis.
@en
type
label
Evidence for chronic inflammat ...... rogressive systemic sclerosis.
@en
prefLabel
Evidence for chronic inflammat ...... rogressive systemic sclerosis.
@en
P2093
P1476
Evidence for chronic inflammat ...... progressive systemic sclerosis
@en
P2093
P304
P356
10.1164/ARRD.1985.131.4.612
P577
1985-04-01T00:00:00Z